Depletion of c-Myc inhibits human colon cancer Colo 320 cells' growth

Cancer Biotherapy and Radiopharmaceuticals

Volumn 23, Issue 2, 2008, Pages 229-237

  Hongxing, Zhang ^a   Nancai, Yu ^a   Wen, Su ^a   Guofu, Huang ^a   Yanxia, Wu ^a   Hanju, Huang ^b   Qian, Liu ^a   Wei, Ma ^a   Yandong, Yi ^a   Hao, Huang ^a,b  

^a Wuhan First Hospital   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

c Myc; Colo 320 cells; Proliferation; Short hairpin RNA

Indexed keywords

AGAR; DNA; MESSENGER RNA; MYC PROTEIN; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; COLON CANCER; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; FLOW CYTOMETRY; GENE SILENCING; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS C-MYC; RNA INTERFERENCE;

EID: 43049107580     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.0441     Document Type: Article

References (24)

1. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002;31:925.
2. Martinez ME. Primary prevention of colorectal cancer: Lifestyle, nutrition, exercise. Recent Results Cancer Res 2005;166:177.
3. Pelengaris S, Khan M, Evan G. c-Myc: More than just a matter of life and death. Nat Rev Cancer 2002;2:764.
4. Grandori C, Cowley SM, James LP, et al. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000;16:653.
5. Erisman MD, Rothberg PG, Diehl RE, et al. Deregulation of c-Myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol Cell Biol 1985;5:1969.
6. Smith DR, Myint T, Goh HS. Overexpression of the c-Myc proto-oncogene in colorectal carcinoma. Br J Cancer 1993;68:407.
7. Van de Wetering M, Sancho E, Verweij C, et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002;111:241.
8. Doisneau-Sixou SF, Sergio CM, et al. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer 2003;10:179.
9. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806.
10. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004;431:371.
11. Yu JY, Deruiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002;99:6047.
12. Dasgupta R, Perrimon N. Using RNAi to catch Drosophila genes in a web of interactions: Insights into cancer research. Oncogene 2004;23:8359.
13. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;441:494.
14. Elbashir SM, Martinez J, Patkaniowska A, et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO 2001;20:6877.
15. Elbashir SM, Harborth J, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002;26:199.
16. Malumbres M, Barbacid M. To cycle or not to cycle: A critical decision in cancer. Nat Rev Cancer 2001;1:222.
17. Felsher DW, Bishop JM. Reversible tumorigenesis by Myc in hematopoietic lineages. Mol Cell 1999;4:199.
18. Pelengaris S, Littlewood T, Khan M, et al. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 1999;3:565.
19. Jain M, Arvanitis C, Chu K, et al. Sustained loss of a neoplastic phenotype by brief inactivation of Myc. Science 2002;297:102.
20. D'Cruz CM, Gunther EJ, Boxer RB, et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 2001;7:235.
21. Pelengaris S, Khan M, Evan GI, et al. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 2002;109:321.
22. Karlsson A, Giuriato S, Tang F, et al. Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations. Blood 2003;101:2797.
23. Henriksson M, Luscher B. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 1996;68:109.
24. Huang E, Ishida S, Pittman J, et al. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet 2003;34:226.